Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rite Aid Considers Forming PBM To Balance Losses To Mail Order

Executive Summary

Rite Aid is considering starting a new pharmacy benefit management business only four years after divesting its PBM division PCS

You may also be interested in...



Walgreens Rx Share Growth Outpaces Mail; Strong Pharmacy Sales Continue

Walgreens is gaining share in the U.S. prescription drug market at a faster pace than mail order or any other retail segment, the company declared in its fiscal second quarter earnings release March 22

Merrill Lynch Supports PCS Deal: PBMs May Be Coming Back Into Favor

The most recent sale in the PCS odyssey in search of the right corporate home puts a $1 bil. price on the pharmacy benefit management company.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel